Overview

An Efficacy Study Of Ortataxel In Recurrent Glioblastoma

Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
Italian Study On The Efficacy Of Ortataxel In Recurrent Glioblastoma
Phase:
Phase 2
Details
Lead Sponsor:
Mario Negri Institute for Pharmacological Research
Treatments:
IDN 5109